Loading data
ELVNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 85.86 m USD | 80.78 m USD | 64.57 m USD | 31.02 m USD | 38.44 m USD |
| Operating profit | -119.66 m USD | -104.55 m USD | -83.53 m USD | -38.79 m USD | -51.44 m USD |
| Profit before tax | — | — | — | 1.58 m USD | -51.38 m USD |
| Income tax expense | 0 USD | 232 k USD | 0 USD | 88 k USD | — |
| Net income (reported basis) | -103.7 m USD | -89 m USD | -71.58 m USD | -37.66 m USD | -51.38 m USD |
| Basic earnings per share | -1.83 USD/share | -1.89 USD/share | -2.01 USD/share | -12.05 USD/share | -2.37 USD/share |
| Diluted earnings per share | -1.83 USD/share | -1.89 USD/share | -2.01 USD/share | -12.05 USD/share | -2.37 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.